Dapagliflozin- Cost-effectiveness as an add-on therapy to metformin in the treatment of type 2 diabetes (T2DM) in Argentina and Chile
Abstract
Authors
J.F. Elgart M. Prestes L. Gonzalez S. Asteazaran E. Aiello S. Garrido Lecca A. Alvarez M. Roberts P. Cortes Cuadra J.J. Gagliardino